SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-040431
Filing Date
2008-02-28
Accepted
2008-02-27 20:55:52
Documents
12
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1809837
2 AGREEMENT OF RESIGNATION, APPOINTMENT AND ACCEPTANCE dex43.htm EX-4.3 30614
3 FORMS OF STOCK OPTION GRANT AGREEMENT dex102.htm EX-10.2 57203
4 AMGEN INC. AMENDED AND RESTATED DIRECTOR EQUITY INCENTIVE PROGRAM dex103.htm EX-10.3 58430
5 SECOND AMENDMENT TO THE AMENDED AND RESTATED EMPLOYEE STOCK PURCHASE PLAN dex109.htm EX-10.9 9359
6 FIFTH AMENDMENT TO THE AMGEN NONQUALIFIED DEFERRED COMPENSATION PLAN dex1033.htm EX-10.33 4326
7 AMENDMENT NO. 6 TO THE ENBREL SUPPLY AGREEMENT dex1063.htm EX-10.63 28510
8 SUBSIDIARIES OF THE COMPANY dex21.htm EX-21 1947
9 RULE 13A-14(A) CERTIFICATIONS dex31.htm EX-31 20204
10 SECTION 1350 CERTIFICATIONS dex32.htm EX-32 9134
11 GRAPHIC g72621g15t30.jpg GRAPHIC 54867
12 GRAPHIC g72621g65t30.jpg GRAPHIC 146732
  Complete submission text file 0001193125-08-040431.txt   2309146
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-12477 | Film No.: 08648254
SIC: 2836 Biological Products, (No Diagnostic Substances)